Roche Registration Ltd.
41 products tracked · names used in filings: Roche Registration Ltd., Roche Registration GmbH, Roche Registration Limited
Upcoming milestones
No upcoming milestones listed.
Recent milestones
Fri 18 Sep 2026🇪🇺 EU approval (EC decision)
Susvimo (ranibizumab) approved in the EU
Marketing authorisation to Roche Registration GmbH; Additional monitoring · source
Thu 23 Jul 2026🇪🇺 CHMP positive opinion
Susvimo (ranibizumab): CHMP positive opinion
Roche Registration GmbH; Additional monitoring · source
Products
| Product | Status | Approved | |
|---|---|---|---|
| 🇪🇺 | Susvimo ranibizumab | Application withdrawn | |
| 🇪🇺 | Elevidys delandistrogene moxeparvovec | Refused | |
| 🇪🇺 | Susvimo ranibizumab | Authorised | 2026-09-18 |
| 🇪🇺 | Itovebi inavolisib | Authorised | 2025-07-18 |
| 🇪🇺 | Piasky crovalimab | Authorised | 2024-08-22 |
| 🇪🇺 | Columvi glofitamab | Authorised | 2023-07-07 |
| 🇪🇺 | Vabysmo faricimab | Authorised | 2022-09-15 |
| 🇪🇺 | Lunsumio mosunetuzumab | Authorised | 2022-06-03 |
| 🇪🇺 | Ronapreve casirivimab;imdevimab | Withdrawn | 2021-11-12 |
| 🇪🇺 | Enspryng satralizumab | Authorised | 2021-06-24 |
| 🇪🇺 | Evrysdi risdiplam | Authorised | 2021-03-26 |
| 🇪🇺 | Xofluza baloxavir marboxil | Authorised | 2021-01-07 |
| 🇪🇺 | Phesgo pertuzumab;trastuzumab | Authorised | 2020-12-21 |
| 🇪🇺 | Rozlytrek entrectinib | Authorised | 2020-07-31 |
| 🇪🇺 | Polivy polatuzumab vedotin | Authorised | 2020-01-16 |
| 🇪🇺 | Hemlibra emicizumab | Authorised | 2018-02-23 |
| 🇪🇺 | Ocrevus ocrelizumab | Authorised | 2018-01-08 |
| 🇪🇺 | Tecentriq atezolizumab | Authorised | 2017-09-20 |
| 🇪🇺 | Alecensa alectinib | Authorised | 2017-02-16 |
| 🇪🇺 | Cotellic cobimetinib | Authorised | 2015-11-20 |
| 🇪🇺 | Gazyvaro obinutuzumab | Authorised | 2014-07-22 |
| 🇪🇺 | Kadcyla trastuzumab emtansine | Authorised | 2013-11-15 |
| 🇪🇺 | Erivedge vismodegib | Authorised | 2013-07-12 |
| 🇪🇺 | Perjeta pertuzumab | Authorised | 2013-03-04 |
| 🇪🇺 | Zelboraf vemurafenib | Authorised | 2012-02-17 |
| 🇪🇺 | RoActemra tocilizumab | Authorised | 2009-01-16 |
| 🇪🇺 | Mircera methoxy polyethylene glycol-epoetin beta | Authorised | 2007-07-20 |
| 🇪🇺 | Avastin bevacizumab | Authorised | 2005-01-12 |
| 🇪🇺 | Bondenza (previously Ibandronic Acid Roche) ibandronic acid | Withdrawn | 2004-02-23 |
| 🇪🇺 | Fuzeon enfuvirtide | Authorised | 2003-05-27 |
| 🇪🇺 | Tamiflu oseltamivir | Authorised | 2002-06-20 |
| 🇪🇺 | Herceptin trastuzumab | Authorised | 2000-08-28 |
| 🇪🇺 | Zenapax daclizumab | Withdrawn | 1999-02-26 |
| 🇪🇺 | Fortovase saquinavir | Withdrawn | 1998-08-20 |
| 🇪🇺 | MabThera rituximab | Authorised | 1998-06-02 |
| 🇪🇺 | Viracept nelfinavir | Withdrawn | 1998-01-22 |
| 🇪🇺 | NeoRecormon epoetin beta | Authorised | 1997-07-16 |
| 🇪🇺 | Invirase saquinavir | Withdrawn | 1996-10-03 |
| 🇪🇺 | Ecokinase reteplase | Withdrawn | 1996-08-29 |
| 🇪🇺 | Destara ibandronic acid | Withdrawn | 1996-06-25 |
| 🇪🇺 | CellCept mycophenolate mofetil | Authorised | 1996-02-14 |
Information from official EMA, FDA, Federal Register and SEC records. Dates marked company-announced come from the company's own SEC filing; dates marked estimate are calculated, not official. Not investment or medical advice; always confirm on the source.